A <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Regulatory Mutant Has Reduced Capsule Expression but Retains Hypermucoviscosity

ABSTRACT The polysaccharide capsule is an essential virulence factor for Klebsiella pneumoniae in both community-acquired hypervirulent strains as well as health care-associated classical strains that are posing significant challenges due to multidrug resistance. Capsule production is known to be tr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kimberly A. Walker, Taryn A. Miner, Michelle Palacios, Dominika Trzilova, Daniel R. Frederick, Christopher A. Broberg, Victoria E. Sepúlveda, Joshua D. Quinn, Virginia L. Miller
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
HMV
Acceso en línea:https://doaj.org/article/d253aa4c055244b39986388f75d67fdc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d253aa4c055244b39986388f75d67fdc
record_format dspace
spelling oai:doaj.org-article:d253aa4c055244b39986388f75d67fdc2021-11-15T15:55:24ZA <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Regulatory Mutant Has Reduced Capsule Expression but Retains Hypermucoviscosity10.1128/mBio.00089-192150-7511https://doaj.org/article/d253aa4c055244b39986388f75d67fdc2019-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00089-19https://doaj.org/toc/2150-7511ABSTRACT The polysaccharide capsule is an essential virulence factor for Klebsiella pneumoniae in both community-acquired hypervirulent strains as well as health care-associated classical strains that are posing significant challenges due to multidrug resistance. Capsule production is known to be transcriptionally regulated by a number of proteins, but very little is known about how these proteins collectively control capsule production. RmpA and RcsB are two known regulators of capsule gene expression, and RmpA is required for the hypermucoviscous (HMV) phenotype in hypervirulent K. pneumoniae strains. In this report, we confirmed that these regulators performed their anticipated functions in the ATCC 43816 derivative, KPPR1S: rcsB and rmpA mutants are HMV negative and have reduced capsule gene expression. We also identified a novel transcriptional regulator, RmpC, encoded by a gene near rmpA. The ΔrmpC strain has reduced capsule gene expression but retains the HMV phenotype. We further showed that a regulatory cascade exists in which KvrA and KvrB, the recently characterized MarR-like regulators, and RcsB contribute to capsule regulation through regulation of the rmpA promoter and through additional mechanisms. In a murine pneumonia model, the regulator mutants have a range of colonization defects, suggesting that they regulate virulence factors in addition to capsule. Further testing of the rmpC and rmpA mutants revealed that they have distinct and overlapping functions and provide evidence that HMV is not dependent on overproduction of capsule. This distinction will facilitate a better understanding of HMV and how it contributes to enhanced virulence of hypervirulent strains. IMPORTANCE Klebsiella pneumoniae continues to be a substantial public health threat due to its ability to cause health care-associated and community-acquired infections combined with its ability to acquire antibiotic resistance. Novel therapeutics are needed to combat this pathogen, and a greater understanding of its virulence factors is required for the development of new drugs. A key virulence factor for K. pneumoniae is the capsule, and community-acquired hypervirulent strains produce a capsule that causes hypermucoidy. We report here a novel capsule regulator, RmpC, and provide evidence that capsule production and the hypermucoviscosity phenotype are distinct processes. Infection studies showing that this and other capsule regulator mutants have a range of phenotypes indicate that additional virulence factors are in their regulons. These results shed new light on the mechanisms controlling capsule production and introduce targets that may prove useful for the development of novel therapeutics for the treatment of this increasingly problematic pathogen.Kimberly A. WalkerTaryn A. MinerMichelle PalaciosDominika TrzilovaDaniel R. FrederickChristopher A. BrobergVictoria E. SepúlvedaJoshua D. QuinnVirginia L. MillerAmerican Society for MicrobiologyarticleHMVRmpARmpCcapsular polysaccharidehypervirulentMicrobiologyQR1-502ENmBio, Vol 10, Iss 2 (2019)
institution DOAJ
collection DOAJ
language EN
topic HMV
RmpA
RmpC
capsular polysaccharide
hypervirulent
Microbiology
QR1-502
spellingShingle HMV
RmpA
RmpC
capsular polysaccharide
hypervirulent
Microbiology
QR1-502
Kimberly A. Walker
Taryn A. Miner
Michelle Palacios
Dominika Trzilova
Daniel R. Frederick
Christopher A. Broberg
Victoria E. Sepúlveda
Joshua D. Quinn
Virginia L. Miller
A <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Regulatory Mutant Has Reduced Capsule Expression but Retains Hypermucoviscosity
description ABSTRACT The polysaccharide capsule is an essential virulence factor for Klebsiella pneumoniae in both community-acquired hypervirulent strains as well as health care-associated classical strains that are posing significant challenges due to multidrug resistance. Capsule production is known to be transcriptionally regulated by a number of proteins, but very little is known about how these proteins collectively control capsule production. RmpA and RcsB are two known regulators of capsule gene expression, and RmpA is required for the hypermucoviscous (HMV) phenotype in hypervirulent K. pneumoniae strains. In this report, we confirmed that these regulators performed their anticipated functions in the ATCC 43816 derivative, KPPR1S: rcsB and rmpA mutants are HMV negative and have reduced capsule gene expression. We also identified a novel transcriptional regulator, RmpC, encoded by a gene near rmpA. The ΔrmpC strain has reduced capsule gene expression but retains the HMV phenotype. We further showed that a regulatory cascade exists in which KvrA and KvrB, the recently characterized MarR-like regulators, and RcsB contribute to capsule regulation through regulation of the rmpA promoter and through additional mechanisms. In a murine pneumonia model, the regulator mutants have a range of colonization defects, suggesting that they regulate virulence factors in addition to capsule. Further testing of the rmpC and rmpA mutants revealed that they have distinct and overlapping functions and provide evidence that HMV is not dependent on overproduction of capsule. This distinction will facilitate a better understanding of HMV and how it contributes to enhanced virulence of hypervirulent strains. IMPORTANCE Klebsiella pneumoniae continues to be a substantial public health threat due to its ability to cause health care-associated and community-acquired infections combined with its ability to acquire antibiotic resistance. Novel therapeutics are needed to combat this pathogen, and a greater understanding of its virulence factors is required for the development of new drugs. A key virulence factor for K. pneumoniae is the capsule, and community-acquired hypervirulent strains produce a capsule that causes hypermucoidy. We report here a novel capsule regulator, RmpC, and provide evidence that capsule production and the hypermucoviscosity phenotype are distinct processes. Infection studies showing that this and other capsule regulator mutants have a range of phenotypes indicate that additional virulence factors are in their regulons. These results shed new light on the mechanisms controlling capsule production and introduce targets that may prove useful for the development of novel therapeutics for the treatment of this increasingly problematic pathogen.
format article
author Kimberly A. Walker
Taryn A. Miner
Michelle Palacios
Dominika Trzilova
Daniel R. Frederick
Christopher A. Broberg
Victoria E. Sepúlveda
Joshua D. Quinn
Virginia L. Miller
author_facet Kimberly A. Walker
Taryn A. Miner
Michelle Palacios
Dominika Trzilova
Daniel R. Frederick
Christopher A. Broberg
Victoria E. Sepúlveda
Joshua D. Quinn
Virginia L. Miller
author_sort Kimberly A. Walker
title A <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Regulatory Mutant Has Reduced Capsule Expression but Retains Hypermucoviscosity
title_short A <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Regulatory Mutant Has Reduced Capsule Expression but Retains Hypermucoviscosity
title_full A <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Regulatory Mutant Has Reduced Capsule Expression but Retains Hypermucoviscosity
title_fullStr A <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Regulatory Mutant Has Reduced Capsule Expression but Retains Hypermucoviscosity
title_full_unstemmed A <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Regulatory Mutant Has Reduced Capsule Expression but Retains Hypermucoviscosity
title_sort <named-content content-type="genus-species">klebsiella pneumoniae</named-content> regulatory mutant has reduced capsule expression but retains hypermucoviscosity
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/d253aa4c055244b39986388f75d67fdc
work_keys_str_mv AT kimberlyawalker anamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT tarynaminer anamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT michellepalacios anamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT dominikatrzilova anamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT danielrfrederick anamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT christopherabroberg anamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT victoriaesepulveda anamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT joshuadquinn anamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT virginialmiller anamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT kimberlyawalker namedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT tarynaminer namedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT michellepalacios namedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT dominikatrzilova namedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT danielrfrederick namedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT christopherabroberg namedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT victoriaesepulveda namedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT joshuadquinn namedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
AT virginialmiller namedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontentregulatorymutanthasreducedcapsuleexpressionbutretainshypermucoviscosity
_version_ 1718427179672403968